Impact of patient financial incentives on participation and outcomes in a statin pill-splitting program

American Journal of Managed Care

Volumn 13, Issue 6 I, 2007, Pages 298-304

  Hae, Mi Choe ^a,c,f   Stevenson, James G ^a,c   Streetman, Daniel S ^a   Heisler, Michele ^b,d   Standiford, Connie J ^b,c   Piette, John D ^b,d,e  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f East Ann Arbor Health Center Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; PRAVASTATIN; SIMVASTATIN;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; BILLING AND CLAIMS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; EUROPEAN AMERICAN; FEMALE; FINANCIAL INCENTIVE; FINANCIAL MANAGEMENT; HEALTH PLAN EMPLOYER DATA AND INFORMATION SET; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; MONEY; NESTED RANDOMIZED TRIAL; PATIENT COMPLIANCE; PATIENT SATISFACTION; PILL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REWARD; TREATMENT OUTCOME;

COST SAVINGS; DECISION MAKING; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MANAGED CARE PROGRAMS; MICHIGAN; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PATIENT PARTICIPATION; PATIENT SATISFACTION; PRESCRIPTIONS, DRUG; REIMBURSEMENT, INCENTIVE; SELF ADMINISTRATION; TABLETS;

EID: 34250822944     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Carr-Lopez SM, Mallett MS, Morse T. The pill splitter: barrier to compliance or cost-saving instrument? Am J Health Syst Pharm. 1995;52:2707-2708.
2. Fawell NG, Cookson TL, Scranton SS. Relationship between pill splitting and compliance, drug acquisition cost, and patient acceptance. Am J Health Syst Pharm. 1999;56:2542-2545.
3. Duncan MC, Castle SS, Streetman DS. Effect of tablet splitting on serum cholesterol concentrations. Ann Pharmacother. 2002;36:205-209.
4. McDevitt JT, Gurst AH, Chen Y. Accuracy of pill splitting. Pharmacotherapy. 1998;18:193-197.
5. Rindone JP. Evaluation of pill-splitting in patients taking lisinopril for hypertension. J Clin Outcomes Manag. 2000;7:22-24.
6. Gee M, Hasson NK, Hahn T, et al. Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Manag Care Pharm. 2002;8:453-458.
7. Stafford RS, Radley DC. The potential of pill splitting to achieve cost savings. Am J Manag Care. 2002;8:706-712.
8. Bachynsky J, Wiens C, Melnychuk K. The practice of splitting tablets - cost and therapeutic aspects. Pharmacoeconomics. 2002;20:339-346.
9. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Med Care. 1988;26:814-823.